Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Wester

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Biological Trace Element Research|May 15, 2003
Selenium protection against mercury-induced apoptosis and growth inhibition in cultured K-562 cellsPeter Frisk, Kenneth Wester, Amer Yaqob, et al.
Nuclear Medicine and Biology|December 6, 2011
Comparative biodistribution of imaging agents for in vivo molecular profiling of disseminated prostate cancer in mice bearing prostate cancer xenografts: focus on 111In- and 125I-labeled anti-HER2 humanized monoclonal trastuzumab and ABY-025 affibodyJennie Malmberg, Mattias Sandström, Kenneth Wester, et al.
International Journal of Oncology|August 3, 2007
EGFR, HER2 and HER3 expression in esophageal primary tumours and corresponding metastasesQichun Wei, Lirong Chen, Liming Sheng, et al.
Journal of Immunological Methods|September 5, 2006
Multiplexed PrEST immunization for high-throughput affinity proteomicsKarin Larsson, Kenneth Wester, Peter Nilsson, et al.
Neuroscience Letters|April 9, 2008
Expression profile of PRAF2 in the human brain and enrichment in synaptic vesiclesDana-Lynn T Koomoa, Ramon Christopher V Go, Kenneth Wester, et al.
Radiology and Oncology|March 27, 2015
EGFR-expression in primary urinary bladder cancer and corresponding metastases and the relation to HER2-expression. On the possibility to target these receptors with radionuclidesJörgen Carlsson, Kenneth Wester, Manuel De La Torre, et al.
BJU International|April 21, 2005
Analysis of HER2 expression in primary urinary bladder carcinoma and corresponding metastasesTruls Gårdmark, Kenneth Wester, Manuel De la Torre, et al.
Acta Oncologica (Stockholm, Sweden)|August 28, 2002
HER-2--a possible target for therapy of metastatic urinary bladder carcinomaKenneth Wester, Anna Sjöström, Manuel de la Torre, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|August 8, 2008
Evaluation of monospecific antibodies: a comparison study with commercial analogs using immunohistochemistry on tissue microarraysLinda Paavilainen, Henrik Wernérus, Peter Nilsson, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|November 11, 2009
The impact of tissue fixatives on morphology and antibody-based protein profiling in tissues and cellsLinda Paavilainen, Asa Edvinsson, Anna Asplund, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Biological Trace Element Research|May 15, 2003
Selenium protection against mercury-induced apoptosis and growth inhibition in cultured K-562 cellsPeter Frisk, Kenneth Wester, Amer Yaqob, et al.
Nuclear Medicine and Biology|December 6, 2011
Comparative biodistribution of imaging agents for in vivo molecular profiling of disseminated prostate cancer in mice bearing prostate cancer xenografts: focus on 111In- and 125I-labeled anti-HER2 humanized monoclonal trastuzumab and ABY-025 affibodyJennie Malmberg, Mattias Sandström, Kenneth Wester, et al.
International Journal of Oncology|August 3, 2007
EGFR, HER2 and HER3 expression in esophageal primary tumours and corresponding metastasesQichun Wei, Lirong Chen, Liming Sheng, et al.
Journal of Immunological Methods|September 5, 2006
Multiplexed PrEST immunization for high-throughput affinity proteomicsKarin Larsson, Kenneth Wester, Peter Nilsson, et al.
Neuroscience Letters|April 9, 2008
Expression profile of PRAF2 in the human brain and enrichment in synaptic vesiclesDana-Lynn T Koomoa, Ramon Christopher V Go, Kenneth Wester, et al.
Radiology and Oncology|March 27, 2015
EGFR-expression in primary urinary bladder cancer and corresponding metastases and the relation to HER2-expression. On the possibility to target these receptors with radionuclidesJörgen Carlsson, Kenneth Wester, Manuel De La Torre, et al.
BJU International|April 21, 2005
Analysis of HER2 expression in primary urinary bladder carcinoma and corresponding metastasesTruls Gårdmark, Kenneth Wester, Manuel De la Torre, et al.
Acta Oncologica (Stockholm, Sweden)|August 28, 2002
HER-2--a possible target for therapy of metastatic urinary bladder carcinomaKenneth Wester, Anna Sjöström, Manuel de la Torre, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|August 8, 2008
Evaluation of monospecific antibodies: a comparison study with commercial analogs using immunohistochemistry on tissue microarraysLinda Paavilainen, Henrik Wernérus, Peter Nilsson, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|November 11, 2009
The impact of tissue fixatives on morphology and antibody-based protein profiling in tissues and cellsLinda Paavilainen, Asa Edvinsson, Anna Asplund, et al.
Pageof 5